ImmuPharma Company

ImmuPharma focuses in developing pioneering and novel drugs in specialist therapeutic areas where there is a distinct lack of existing treatments, avoiding primary care (diseases treated by GPs) where many treatments exist. This is consistent with the trends in the pharmaceutical industry.
Since our foundation, our research strategy has been to work closely with the largest fundamental research organisation in Europe, the Centre National de la Recherche Scientifique, (CNRS) in France. This collaboration enables us to access innovative research with substantial embedded value at a relatively low cost, and to work with many leading scientists and doctors. ImmuPharma has exclusive rights to all its intellectual property assets.
Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: Westminster, Westminster, United Kingdom
Founded Date: 1999
Employees Number: 1-10
Funding Status: IPO

Visit Website
Register and Claim Ownership